Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Classificação em ações #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Preço da ação
$1.50
Última sincronização: 2026-09-21
Valor de mercado
$3.63M
Variação (1 dia)
-4.46%
Variação (1 ano)
-72.68%
País
MY
Negociar BioNexus Gene Lab Corp. (BGLC)

Categoria

Histórico de rendimento de dividendos para BioNexus Gene Lab Corp. (BGLC)
O rendimento de dividendos (TTM) da BioNexus Gene Lab Corp. (símbolo da ação: BGLC) em 2023-12-31 é: 0.00%
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para BioNexus Gene Lab Corp. (BGLC) de 2016 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
0.74%
US
1.94%
US
0.00%
US
0.58%
US
0.00%
US